Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
02/2012
02/22/2012CN102361873A Fused pyrimidine-dione derivatives as trpa1 modulators
02/22/2012CN102361872A Fused pyrimidines as AKT inhibitors
02/22/2012CN102361859A Heteroaryl compounds useful as Raf kinase inhibitors
02/22/2012CN102358741A Azepinoindole derivatives as pharmaceutical agents
02/22/2012CN101824037B 一种西他列汀游离碱的制备方法 A method for the preparation of sitagliptin free base
02/22/2012CN101501039B 吡咯并[1,2-b]哒嗪酮化合物 Pyrrolo [1,2-b] pyridazine-one compounds
02/21/2012US8119819 Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators
02/21/2012US8119816 Merocyanine dye and use thereof
02/21/2012US8119777 Ink jet dye design
02/21/2012US8119635 Diazabicyclic central nervous system active agents
02/21/2012US8119631 Inhibitors of interleukin-1β converting enzyme
02/21/2012US8119629 Carboxamide GABAA α2 modulators
02/21/2012US8119628 Pyrrolidine fused indolobenzadiazepine HCV NS5B inhibitors
02/21/2012US8119566 use as pesticides and/or herbicides and/or microbicides; for the selective control of weeds; synergistic; low application rates and concentrations; in particular in cereals (especially wheat)
02/21/2012CA2524726C Heterocyclyl-substituted dihydroquinazolines and use thereof as an antiviral agent
02/16/2012WO2012021712A1 Tetracycline analogs
02/16/2012WO2012021591A1 Hepatitis c virus inhibitors
02/16/2012WO2012020022A1 6-cycloalkyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a inhibitors
02/16/2012WO2012020008A1 Inhibitors of bruton's tyrosine kinase
02/16/2012WO2012019430A1 Phthalazinone derivative, and preparation method and pharmaceutical use thereof
02/16/2012WO2012019427A1 Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof
02/16/2012WO2012019426A1 Phthalazinone derivative, and preparation method and pharmaceutical use thereof
02/16/2012US20120041202 Preparation of C-Pyrazine-Methylamines
02/16/2012US20120041198 Process for Preparing 5,7 Diaminopyrazolo [1,5-a] Pyrimidine Compounds
02/16/2012US20120041192 Macrocyclic derivatives of glycolurils, and methods of preparing and using the same
02/16/2012US20120041191 Phosphinate ruthenium complexes
02/16/2012US20120041190 Macrocycles as factor xia inhibitors
02/16/2012US20120041007 Cdk inhibitor salts
02/16/2012US20120041004 Fused pyrimidine-dione derivatives as trpai modulators
02/16/2012US20120041003 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme
02/16/2012US20120041002 Substituted pyrazolo [1,5-a] pyrimidines as metabotropic glutamate antagonists
02/16/2012US20120040999 P38 kinase inhibiting agents
02/16/2012US20120040987 Derivatives of 6-(6-nh-substituted-triazolopyridazine-sulfanyl) benzothiazoles and benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
02/16/2012US20120040979 Imidazo[1,2-b]pyridazines, processes, uses, intermediates and compositions
02/16/2012US20120040975 Bridged bicyclic heterocycle derivatives and methods of use thereof
02/16/2012US20120040973 Derivatives of [1,3]oxazin-2-one useful for the treatment of metabolic diseases such as lipid disorders
02/16/2012US20120040965 Substituted azepino[4,3-b]indoles, pharmacological composition and a method for the production and use thereof
02/16/2012US20120040963 4-Biphenyl-Substituted Pyrazolidin-3,5-Dione Derivatives
02/16/2012US20120040961 Pyrimido-diazepinone kinase scaffold compounds and methods of treating disorders
02/16/2012US20120040949 Inhibitors of Bruton's Tyrosine Kinase
02/16/2012US20120040918 Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid
02/16/2012US20120040380 Optically-detectable enzyme substrates and their method of use
02/16/2012US20120040020 Compounds useful as inhibitors of atr kinase
02/16/2012US20120039816 Use of 7-chloro-n,n,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide as a biomarker of peripheral benzodiazepine receptor levels
02/16/2012DE102010034496A1 Photosensiver molekularer Schalter mit einem Chelat-Liganden und isomerisierbarem photochromem System Photosensiver molecular switch with a chelate ligand and isomerizable photochromic system
02/16/2012CA2808061A1 Hepatitis c virus inhibitors
02/16/2012CA2807687A1 6-cycloalkyl-1, 5-dihydro-pyrazolo (3,4-d) pyrimidin-4-one derivatives and their use as pde9a inhibitors
02/16/2012CA2807634A1 Inhibitors of bruton's tyrosine kinase
02/16/2012CA2806324A1 Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof
02/15/2012EP2418209A1 Aurora kinase modulators and method of use
02/15/2012EP2417140A1 Inhibitors of hiv replication
02/15/2012EP2417138A1 Pyrazolo [1, 5-a] pyrimidine derivatives as mtor inhibitors
02/15/2012EP2417137A1 Pyrrolopyrrole derivatives, their manufacture and use as semiconductors
02/15/2012EP2417133A1 Compounds and methods for antiviral treatment
02/15/2012EP2125823B1 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine derivatives
02/15/2012EP1395595B1 Tetramerous derivative of indole-3-carbinol with anti-carcinogenic activity and method of synthesis of said derivative
02/15/2012CN1942472B 回折拟态及其相关方法 Mimicry and related methods folded back
02/15/2012CN102356109A Inclusion complex, curing agent, cure accelerator, epoxy resin composition, and epoxy resin composition for encapsulation of semiconductor
02/15/2012CN102356084A N-[(6-aza-bicyclo[3.2.1]oct-5-yl)-aryl-methyl]-heterobenzamide derivatives, preparation thereof, and therapeutic use of same
02/15/2012CN102356083A Use of kinase inhibitor for treatment of thymoma
02/15/2012CN102356081A Bicyclic compounds for the reduction of beta-amyloid production
02/15/2012CN102351867A Natural chlorophyll iron calcium salt and preparation method thereof
02/15/2012CN102351866A Phthalocyanine zinc complex and its preparation method
02/15/2012CN102351865A Zinc phthalocyanine derivative and preparation method thereof
02/15/2012CN102351864A Organic-functionalized non-aggregated phthalocyanine and preparation method thereof
02/15/2012CN102351863A Method for extracting qingdainone from isatis tinctoria
02/15/2012CN102351862A Pharmacokinetically improved compounds
02/14/2012US8114993 Use of aryl chlorides in palladium-catalyzed C-H bond functionalization
02/14/2012US8114864 Macrolide antibiotics and their use for medical purposes
02/09/2012WO2012018662A2 Fused-imidazoyl compounds useful as antimicrobial agents
02/09/2012WO2012018058A1 Fused heterocyclic ring compound
02/09/2012WO2012017443A1 Process for preparation of highly pure dialkyl pemetrexed
02/09/2012WO2012017030A1 Compounds with antibacterial activity against clostridium
02/09/2012WO2012016849A1 Process for the homogeneous hydrogenation of (poly)unsaturated hydrocarbons
02/09/2012WO2011133637A3 Compounds and methods for kinase modulation, and indications therefor
02/09/2012US20120035351 Volatile Imidazoles and Group 2 Imidazole Based Metal Precursors
02/09/2012US20120035153 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
02/09/2012US20120035102 Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
02/09/2012US20120035070 Coelenterazine analogs and manufacturing method thereof
02/09/2012US20120034660 Process for producing optically active succinimide derivatives and intermediates thereof
02/09/2012US20120032158 Charge transport compositions and electronic devices made with such compositions
02/09/2012DE112010000820T5 Verbindungen für nicht-invasive Messung von Aggregaten von Amyloidpeptiden Compounds for non-invasive measurement of aggregates of amyloid peptides
02/09/2012CA2807093A1 Benzimidazole and azabenzimidazole compounds that inhibit anaplastic lymphoma kinase
02/09/2012CA2805358A1 Compounds with antibacterial activity against clostridium
02/08/2012EP2416397A1 Material for phosphorescent light-emitting element and organic electroluminescent element using same
02/08/2012EP2415840A1 Novel azomethine compound and thermal transfer sheet using the same azomethine compound pigment
02/08/2012EP2415773A2 Organic electronic device, compounds for same, and terminal
02/08/2012EP2415772A1 Material for use in phosphorescent device and organic electroluminescent device using same
02/08/2012EP2415474A1 Pharmaceutical composition for treatment or prevention of ophthalmic diseases
02/08/2012EP2414365A1 SUBSTITUTED [1,2,4¨TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
02/08/2012EP2414364A1 SUBSTITUTED Ý1,2,4¨TRIAZOLOÝ1,5-a¨PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
02/08/2012EP2414363A1 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d]pyrimidin-4-one derivatives and their use as pde9a modulators
02/08/2012EP2414361A1 Substituted heterocyclic compounds
02/08/2012EP2414359A1 Peri-fused pyrazolo-pyrimidine compounds
02/08/2012EP2414334A1 Bridged bicyclic heterocycle derivatives and methods of use thereof
02/08/2012EP2414289A2 Method for preparing cha-type molecular sieves using novel structure directing agents
02/08/2012EP2414044A1 Substituted indolo-piperidine compounds
02/08/2012EP2413932A1 Inhibitors of akt activity
02/08/2012EP2321321B1 Triazolo [4, 5-d]pyramidine derivatives and their use as purine receptor antagonists
02/08/2012EP2044033B1 A regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles